Download in electronic PDF format for $25

Kalchem International - Chemicals and Compounding Supplies

Search the Complete Journal Archives

Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs

Author(s):  Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei

Issue:  Jan/Feb 2011 - Volume 15, Number 1
View All Articles in Issue

Abstract:  The purpose of this study was to determine the stability of an extemporaneously prepared intranasal formulation of midazolam for the treatment of status epileptus in dogs. An aqueous solution of midazolam (50 mg/mL) was prepared by dissolving 500 mg of midazolam powder in sterile water for injection containing carbopol (0.4%) and benzalkonium chloride (0.01%), pH 2.8 to 3.0. Five identical formulations were prepared and placed in lightresistant glass containers and stored under refrigeration (3°C to 5°C) and at room temperature (22°C to 24°C). Samples were collected from each container at 0, 2, 4, 8, and at 1, 3, 7, 14, 30, 45, 60, and 90 days. Each sample was diluted to an expected concentration of 200 mcg/mL and assayed using high-performance liquid chromatographic analysis with ultraviolet detection. The formulation was shown to be stable for 30 days under refrigeration and at room temperature. The formulation was shown to be unstable under both storage conditions at and beyond 45 days. Stability is defined as the retention of at least 90% of the initial concentration. It is suggested that the extemporaneously prepared midazolam intranasal formulation can safely be stored for 30 days at room temperature or under refrigeration.

Related Keywords: Deborah Lester Elder, PharmD, RPh, Bo Zheng, PhD, Catherine A. White, PhD, Dawei Li, DPhil of Pharmacy Candidate, midazolam, benzodiazepines, intranasal administration, dogs, canine, status epilepticus, antiepileptic drug, stability, storage

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES, VETERINARY, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY, STORAGE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei Jan/Feb 2011 74-77 Buy
Treating Canine Hepatic Disease Davidson Gigi S May/Jun 2003 188 Buy
The Treatment of Canine Atopic Disease Davidson Gigi S May/Jun 2002 210-215 Buy
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R Sep/Oct 2012 431-433 Buy
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin May/Jun 2015 261-267 Buy
A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier Songkro Sarunyoo, Pengmak Somuredee, Seajung Pornyamol, Maneenuan Duangkhae, Kaewnopparat Nattha Sep/Oct 2018 424-432 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Canine Public Servants: Caring for Drug Detection Dogs Davidson Gigi S Sep/Oct 2008 384-390 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug Mar/Apr 2017 95-102 Buy